מי באמת ייצר את חיסוני הקורונה

Moderna → Lonza Group

In May 2020, Moderna and Lonza announced a 10-year strategic collaboration to manufacture Moderna's COVID-19 vaccine (mRNA-1273) at Lonza facilities in the U.S. and Switzerland, aiming to enable production of up to 1 billion doses per year. Lonza was a primary scale-up manufacturing partner, not Moderna's only one.

Vaccine Glass Vials

נדרש על ידי: Moderna, Pfizer

In June 2020, the U.S. Departments of Defense and Health and Human Services awarded Corning $204 million under Operation Warp Speed to rapidly expand domestic production of its Valor Glass vials — designed to fill up to 50% faster and be up to 10 times stronger than traditional vials. Corning was a major, government-selected supplier, not the world's only vial maker.